Cargando…

Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder

BACKGROUND: Arterial stiffness and medial vascular calcification, leading to isolated systolic blood pressure (BP), are major cardiovascular risk factors in patients with chronic kidney disease (CKD) and mineral bone disorders (MBD). The impact of BP on MBD-induced medial vascular calcification in C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larivière, Richard, Ung, Roth-Visal, Picard, Sylvain, Richard, Darren E., Mac-Way, Fabrice, Agharazii, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570511/ https://www.ncbi.nlm.nih.gov/pubmed/37840953 http://dx.doi.org/10.3389/fcvm.2023.1241943

Ejemplares similares

Division of an Iliac Crest Bone Biopsy Specimen to Allow Histomorphometry, Immunohistochemical, Molecular Analysis, and Tissue Banking: Technical Aspect and Applications
por: Picard, Sylvain, et al.
Publicado: (2020)

Progression of Medial Arterial Calcification in CKD
por: Manzoor, Shumila, et al.
Publicado: (2018)

Simultaneous Estimation of Hydrochlorothiazide, Hydralazine Hydrochloride, and Reserpine Using PCA, NAS, and NAS-PCA
por: Sharma, Chetan, et al.
Publicado: (2015)

Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy
por: Bisson, Sarah-Kim, et al.
Publicado: (2018)

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?
por: Jonnalagadda, Venu Gopal, et al.
Publicado: (2017)

The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells
por: Ruiz-Magaña, María J., et al.
Publicado: (2016)

Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial
por: S, Donel, et al.
Publicado: (2023)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

Covalent Adduct Formation between the Antihypertensive Drug Hydralazine and Abasic Sites in Double- and Single-Stranded DNA
por: Melton, Douglas, et al.
Publicado: (2014)

The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension
por: Yuan, Yuan, et al.
Publicado: (2020)

Bone Marrow Adiposity, Bone Mineral Density and Wnt/β-catenin Pathway Inhibitors Levels in Hemodialysis Patients
por: Wang, Yue-Pei, et al.
Publicado: (2022)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

Abdominal aortic calcification in patients with CKD
por: Peeters, Mieke J., et al.
Publicado: (2016)

Association of Chromosome 12 locus with antihypertensive response to hydrochlorothiazide may involve differential YEATS4 expression
por: Duarte, Julio D., et al.
Publicado: (2012)

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

Arterial Stiffness and Dialysis Calcium Concentration
por: Mac-Way, Fabrice, et al.
Publicado: (2011)

Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide
por: Flack, J M
Publicado: (2007)

Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study
por: Hosoya, Tatsuo, et al.
Publicado: (2011)

Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components
por: Stafylas, Panagiotis, et al.
Publicado: (2015)

Response surface analyses of antihypertensive effects of angiotensin receptor blockers and amlodipine or hydrochlorothiazide combination therapy in patients with essential hypertension
por: Cho, Minhee, et al.
Publicado: (2023)

Rare complication of a commonly used antihypertensive agent: A case of hydralazine‐induced ANCA‐associated vasculitis presenting as rapidly progressive glomerulonephritis
por: Warren, Kayle, et al.
Publicado: (2022)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Clinical Characteristics of Hydralazine-induced Lupus
por: Timlin, Homa, et al.
Publicado: (2019)

Hydralazine-Induced Isolated Lupus Nephritis
por: Khan, Naseer, et al.
Publicado: (2020)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

The Thermodynamics of Medial Vascular Calcification
por: Millán, Ángel, et al.
Publicado: (2021)

Magnesium in CKD: more than a calcification inhibitor?
por: Floege, Jürgen
Publicado: (2014)

Targeting Vascular Calcification in CKD: Time to Redraw the Map
por: O'Neill, W. Charles
Publicado: (2023)

Hydralazine target: From blood vessels to the epigenome
por: Arce, Claudia, et al.
Publicado: (2006)

Influence of hydralazine on the pharmacokinetics of tauromustine (TCNU) in mice.
por: Bibby, M. C., et al.
Publicado: (1992)

Anti-neoplastic properties of hydralazine in prostate cancer
por: Graça, Inês, et al.
Publicado: (2014)

ANA-Negative Hydralazine-Induced Pericardial Effusion
por: Zeitjian, Vicken, et al.
Publicado: (2017)

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD
por: Ramakrishnan, Madhuri, et al.
Publicado: (2020)

The emerging role of iron in heart failure and vascular calcification in CKD
por: Ciceri, Paola, et al.
Publicado: (2020)

Role of gut microbiota‐derived metabolites on vascular calcification in CKD
por: Yin, Li, et al.
Publicado: (2020)

Serum sclerostin in vascular calcification in CKD: a meta-analysis
por: Lin, Yan, et al.
Publicado: (2023)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

Trends in using of antihypertensive medication among US CKD adults, NHANES 2001–2018
por: Li, Fanghua, et al.
Publicado: (2023)

Coronary artery calcification score and common iliac artery calcification score in non‐dialysis CKD patients
por: Mizuiri, Sonoo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rslrkidub8sk3ccqtr5homjb6v